Peptomyc wins Startup Slam competition at BIO-Europe Spring® Barcelona
Neruda Scott (Johnson & Johnson), Bauke Anninga (Innovation Forum), Laura Soucek (Peptomyc) and Emma Kohring (Johnson & Johnson).
Panel of expert judges selects winner from 14 short-listed European start-ups that showed greatest potential for transformative healthcare solutions
Startup Slam sponsor and co-host Johnson & Johnson Innovation recognizes high caliber of entries selected to compete for prestigious award
Peptomyc completes Seed Funding of €1M
Funds will help company reach preclinical validation for lead candidate in glioblastoma – an aggressive and lethal brain tumor – and in other cancer indications.
Peptomyc receives a business grant from ACCIÓ
This second grant in 2 months further supports Peptomyc in its mission to bring novel Myc inhibitors closer to clinical use for cancer treatment.